Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Romania
  4. Bucharest Stock Exchange
  5. Antibiotice S.A.
  6. News
  7. Summary
    ATB   ROATBIACNOR9

ANTIBIOTICE S.A.

(ATB)
  Report
SummaryChartsNewsCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021

05/12/2021 EDT

Antibiotice S.A. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was RON 66.101 million compared to RON 73.631 million a year ago. Operating income was RON 5.271 million compared to RON 5.451 million a year ago. Net income was RON 4.038 million compared to RON 4.080 million a year ago. Basic earnings per share from continuing operations was RON 0.006015 compared to RON 0.006078 a year ago.


© S&P Capital IQ 2021
All news about ANTIBIOTICE S.A.
09/02ANTIBIOTICE S.A. : Ex-dividend day for final dividend
FA
07/26Antibiotice S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
05/12Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
02/26Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2020Antibiotice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
2020ANTIBIOTICE SA : Ex-dividend day for final dividend
FA
2020Antibiotice S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
2019Antibiotice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2019
CI
2019ANTIBIOTICE SA : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2020 347 M 81,4 M 81,4 M
Net income 2020 26,4 M 6,19 M 6,19 M
Net Debt 2020 155 M 36,3 M 36,3 M
P/E ratio 2020 12,4x
Yield 2020 0,68%
Capitalization 387 M 90,7 M 90,7 M
EV / Sales 2019 1,32x
EV / Sales 2020 1,39x
Nbr of Employees 1 415
Free-Float 20,9%
Chart ANTIBIOTICE S.A.
Duration : Period :
Antibiotice S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 0,58 RON
Average target price 0,58 RON
Spread / Average Target 0,69%
Managers and Directors
Ioan Nani Vice Chairman & General Director
Paula-Luminita Coman Finance Director
Ionut Sebastian Iavor Chairman
Cornelia Moraru Director-Technical & Production
Mihaela Mosnegutu Medical Director
Sector and Competitors
1st jan.Capi. (M$)
ANTIBIOTICE S.A.18.52%91
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657